Biovision, the World Life Science Forum is taking place on 13 and 14 April 2016 in Lyon.

Key features include the Catalyzer programme and the Investor Conference, which can be of prime interest to companies in the medtech, biotech, e-health and environment-health sectors.

The Catalyzer Programme helps discover innovative health projects and seed stage start-ups, supports them by putting their ideas in the spotlight, and places them on the fast track towards the fulfilment and realisation of their work. Applicants selected will have the opportunity to pitch their projects in front of an expert during the Catalyzer meetings.

The Investor Conference accelerates the fundraising process of start-ups by putting them in direct contact with potential business and development partners. Applications are open to startups seeking for series A or B funding within 18 months.

Biovision World Life Science Forum is fostering a unique approach to facilitate collaboration between international decision-makers from the academic, civil society, policy-making and private sectors.

Biovision 2016 pattern is dedicated to strengthen action & interaction for innovation with:

• Prospective part with a main theme on “Global health and Prevention” and specific paths (Medecine & Humanities, Vaccines, Cancer Prevention and Digitalized Patients) with workshops , plenary sessions and calls for action.
• Catalyzer & Investors parts with reinforced and segmented sourcing; allowing more specific expertise for the evaluation and the follow up of the projects including financing.

Interested companies should contact Aurélien Riquet, Program Coordinator on +33 (0)4 78 92 74 61 for further information.